Aier Eye Hospital Group Co., Ltd (300015:SHZ) の戦略的SWOT、PESTLE分析、財政インサイト

Report Overview

Report Summary

Aier Eye Hospital Group Co., Ltd Strategic SWOT, PESTLE Analysis and Financial Insights – A 360° Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence, Financial and Operational KPI’s, and Recent Trends Report is a comprehensive and easily accessible overview of Aier Eye Hospital Group Co., Ltd’s business operations. It provides a detailed analysis of the company’s financial and strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company’s performance.

The report begins with in-depth information about Aier Eye Hospital Group Co., Ltd including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company’s key attributes.

Next, the report assesses Aier Eye Hospital Group Co., Ltd’s strategic standing through various analyses. The ESG spotlight evaluates the company’s environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company’s internal strengths and weaknesses, as well as external opportunities and threats. The PESTLE analysis evaluates the external factors impacting the company’s operations and market environment. Additionally, By integrating these strategic analyses, the report offers a comprehensive understanding of Aier Eye Hospital Group Co., Ltd’s overall strategic standing and supports informed decision-making and strategic planning.

The report also covers Aier Eye Hospital Group Co., Ltd’s financial analysis basis of latest income statement, balance sheet, and cash flow statement. Key financial ratios related to profitability, asset turnover, credit, market, and long-term solvency are outlined, providing guidance for investment decisions. Furthermore, the report compares Aier Eye Hospital Group Co., Ltd’s financial parameters with those of its competitors, offering a unique analysis of the competitive landscape. This information helps manage the business environment and improve sales activities by gaining insight into competitors’ operations.

Finally, the report includes recent news and deal activities undertaken by Aier Eye Hospital Group Co., Ltd enhancing awareness of the company’s business trends, growth perspectives, and more.

Key Highlights

The Aier Eye Hospital Group Co. Ltd operates as a leading ophthalmology hospital group. Aier Eye Hospital Group Co. Ltd operates in the healthcare industry, specifically in the ophthalmology hospital sector providing services like myopia surgery, cataract treatment, pediatric eye care and more. Aier Eye Hospital Group Co. Ltd provides a range of eye care services including myopia surgery, cataract surgery, pediatric ophthalmology, eye plastic surgery, myopia prevention and control. The company operates over 400 specialized eye hospitals and centers in China and abroad, with annual outpatient visits exceeding 10 million. Aier uses advanced ophthalmic technology and management concepts to provide high-quality medical services. Founded in 2002, the company is headquartered in Chang Sha Shi, Hu Nan Sheng, China.

Aier Eye Hospital Group Co., Ltd in the News:-

2025-05-20 – Enter ARVO 2025 | Aier Eye Hospital appears on the international stage, demonstrating its scientific research strength and international vision
2025-05-20 – Aier Eye Hospital’s research results on dry eye disease were published on the cover of the international journal Advanced Science
2025-05-16 – 164 out of 1662! Aier Eye Hospital is listed in S&P Global’s "Sustainable Development Yearbook (China Edition) 2025" for the first time
2025-05-16 – "2025 China Brand Value Evaluation Information" released, Aier Eye Hospital brand value reaches new high
2025-04-21 – Aier Eye Hospital was selected as a landmark project of Hunan Province’s "Digital New Infrastructure" to lead the innovation of artificial intelligence scenarios in ophthalmology with digital technology

Scope

• Tactical Analysis:- Various strategic frameworks to gain insights into a company’s competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
• Business Strategy:- Contributes to shaping the company’s overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
• Financial Position:- Provide valuable information on the financial performance and investor sentiment surrounding the company. Indicating the level of confidence and expectations in the company’s future prospects. These components collectively contribute to understanding the financial health and market perception of the company.
• Company Fundamentals:- These fundamentals offer valuable insights into the company’s history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
• Competitive Landscape:- An identification of the company’s main competitors, providing insights into the competitive landscape it operates in.

Reasons to Buy

• Comprehensive Understanding of the Aier Eye Hospital Group Co., Ltd’s internal and external factors through SWOT analysis, PESTLE analysis, Financial Analysis, and Competitors Benchmarking.
• Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
• Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
• Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
• Financial Performance Evaluation provides crucial insights into key financial ratios and trends, supporting better financial decision-making and resource allocation.
• Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.

Additionally, available deep-dive analysis on the company Aier Eye Hospital Group Co., Ltd:
• Aier Eye Hospital Group Co., Ltd Value Chain Analysis
• Aier Eye Hospital Group Co., Ltd Porter’s Five Forces Analysis
• Aier Eye Hospital Group Co., Ltd VRIO Analysis
• Aier Eye Hospital Group Co., Ltd BCG Analysis
• Aier Eye Hospital Group Co., Ltd Segmentation, Targeting and Positioning (STP) Analysis
• Aier Eye Hospital Group Co., Ltd Ansoff Matrix Analysis

Table of Contents

Table of Contents 2
Tables 5
Charts 6
Aier Eye Hospital Group Co., Ltd-Key Company Facts 7
Aier Eye Hospital Group Co., Ltd- Company Description 8
Aier Eye Hospital Group Co., Ltd- Top Executives 9
Aier Eye Hospital Group Co., Ltd- Head Office & Locations 10
Head Office – Country 10
Aier Eye Hospital Group Co., Ltd- Products and Services 11
Services 11
Aier Eye Hospital Group Co., Ltd- Corporate Strategy 12
Aier Eye Hospital Group Co., Ltd- Business Description 15
Clinical Medicine 15
Medical Education 16
Academic Research 16
Overseas Operations 17
Aier Eye Hospital Group Co., Ltd- ESG Spotlight 18
Environment 18
Social 19
Corporate Governance 20
Aier Eye Hospital Group Co., Ltd- SWOT Analysis 22
Overview 22
Strengths 24
Weaknesses 26
Opportunities 28
Threats 30
Aier Eye Hospital Group Co., Ltd– PESTLE Analysis 32
Overview 32
Political Factors 34
Economic Factors 36
Social Factors 37
Technological Factors 38
Legal Factors 39
Environmental Factors 41
Aier Eye Hospital Group Co., Ltd- Financial Deep Dive 43
Share Price Trend – Jul-2024to Jul-2025 (Average Share Closing Price) 43
Profit and Loss Statement 45
Balance Sheet 46
Cash Flow Statement 47
Key Financial Ratio Analysis 48
Aier Eye Hospital Group Co., Ltd- Ratio Charts 49
Activity Ratio Charts 49
Growth Ratios Charts 50
Leverage Ratio Charts 51
Liquidity Ratio Charts 52
Competing Players 53
Snapshot of Competing Players 54
Nova Eye Medical Ltd 54
Key Company Facts 54
Company Description 54
C-MER Eye Care Holdings Ltd 55
Key Company Facts 55
Company Description 55
Eyebright Medical Technology (Beijing) Co Ltd 56
Key Company Facts 56
Company Description 56
Lotus Eye Hospital and Institute Ltd 57
Key Company Facts 57
Company Description 57
Aier Eye Hospital Group Co., Ltd – In the News 58
20-May-2025 -Enter ARVO 2025 | Aier Eye Hospital appears on the international stage, demonstrating its scientific research strength and international vision 58
20-May-2025 -Aier Eye Hospital’s research results on dry eye disease were published on the cover of the international journal Advanced Science 60
16-May-2025 -164 out of 1662! Aier Eye Hospital is listed in S&P Global’s “Sustainable Development Yearbook (China Edition) 2025” for the first time 62
16-May-2025 -“2025 China Brand Value Evaluation Information” released, Aier Eye Hospital brand value reaches new high 64
21-Apr-2025 -Aier Eye Hospital was selected as a landmark project of Hunan Province’s “Digital New Infrastructure” to lead the innovation of artificial intelligence scenarios in ophthalmology with digital technology 66
09-Apr-2025 -APAO 2025丨Aier Eye Hospital expert Professor Hu Yuntao won the Asia-Pacific Ophthalmology Achievement Award 69
27-Mar-2025 -Focusing on one’s efforts and moving towards high-quality development – Aier Eye Hospital’s Pan-Greater Bay Area “3+4” Hospital Work Meeting and “3+4” Hospital Directors’ Surgery Video Observation Meeting were held in Guangzhou 71
25-Mar-2025 -Yuan Bincai, Chairman of the Gansu Provincial Overseas Chinese Federation, and his delegation visited Aier Eye Hospital 75
17-Mar-2025 -Xining Municipal Government Delegation Investigates AIER Eye Hospital, Strategic Cooperation Promotes Development of Ophthalmology 77
06-Mar-2025 -Zhu Wan, Director of the Hunan Provincial Department of Science and Technology, and his delegation visited Aier Eye Hospital to investigate the development of the hospital 78
Appendix 79
Definitions 79
SWOT Analysis 79
PESTLE Analysis 79
Value Chain Analysis 79
ESG Spotlight 79
Financial Deep Dive 79
Financial Ratios- 80
Activity Ratios 80
Growth Ratios 81
Leverage Ratios 82
Liquidity Ratios 83
Market Ratios 84
Profitability Ratios 84
Research Methodology 85
Disclaimer 86
Contact Us 86

Table 1: Aier Eye Hospital Group Co., Ltd – Company Facts 7
Table 2: Aier Eye Hospital Group Co., Ltd – Digital Presence 7
Table 3: Aier Eye Hospital Group Co., Ltd- Top Executives 9
Table 4: Aier Eye Hospital Group Co., Ltd-Services 11
Table 5: Aier Eye Hospital Group Co., Ltd – Share Price Trend – Jul-2024to Jul-2025 43
Table 6: Aier Eye Hospital Group Co., Ltd- Ratio Analysis -2022-2024 48
Table 7: Aier Eye Hospital Group Co., Ltd -Competing Players 53
Table 8: Competing Players – Nova Eye Medical Ltd – Key Company Facts 54
Table 9: Competing Players – C-MER Eye Care Holdings Ltd – Key Company Facts 55
Table 10: Competing Players – Eyebright Medical Technology (Beijing) Co Ltd – Key Company Facts 56
Table 12: Competing Players – Lotus Eye Hospital and Institute Ltd – Key Company Facts 57

Figure 1: Aier Eye Hospital Group Co., Ltd- SWOT Analysis 23
Figure 2: Aier Eye Hospital Group Co., Ltd-PESTLE Analysis 33
Figure 3: Aier Eye Hospital Group Co., Ltd-Average Share Price Trend – Jul-2024to Jul-2025 44
Figure 4: Aier Eye Hospital Group Co., Ltd- Profit and Loss Statement -2022-2024 45
Figure 5: Aier Eye Hospital Group Co., Ltd- Balance Sheet-2022-2024 46
Figure 6: Aier Eye Hospital Group Co., Ltd- Cash Flow Statement 2022-2024 47
Figure 7: Aier Eye Hospital Group Co., Ltd- Activity Ratio Charts 49
Figure 8: Aier Eye Hospital Group Co., Ltd- Growth Ratio Charts (Value %) 50
Figure 9: Aier Eye Hospital Group Co., Ltd- Leverage Ratio Charts 51
Figure 10: Aier Eye Hospital Group Co., Ltd- Liquidity Ratio Charts 52

Quaintel Research（クアインテルリサーチ）は200セクター超における世界の企業の競合ベンチマーキング、販売情報、投資魅力度、イノベーションについてデータ駆動型の実用的な情報を提供する専門調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業同一住所内人数無制限でレポートファイルのご共有が可能です。
  • エンタープライズライセンス
    • 同一企業であれば、人数無制限でレポートファイルの閲ご共有が可能です。
• 納期
  • ご注文後2-3営業日以内
• 納品形態
  • Eメール

注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでのご注文をお待ちしております。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新調査レポート

• Benteler International AGの戦略的SWOTインサイト 2025-04-30
• Schauinsland-Reisen GmbHの戦略的SWOTインサイト 2025-04-30
• Seat, S.A.の戦略的SWOTインサイト 2025-04-30
• Havas N.A.の戦略的SWOTインサイト 2025-04-30
• TelevisaUnivision Incの戦略的SWOTインサイト 2025-04-30

Quaintel Research 出版レポート一覧

Quaintel Research出版の市場調査レポートに関するご質問やサンプルページのご依頼等はいつでもお気軽にお問合せください。